J Biol Chem, Vol. 275, Issue 13, 9296-9302, March 31, 2000
The Nonbilayer/Bilayer Lipid Balance in Membranes
REGULATORY ENZYME IN ACHOLEPLASMA LAIDLAWII IS
STIMULATED BY METABOLIC PHOSPHATES, ACTIVATOR PHOSPHOLIPIDS, AND
DOUBLE-STRANDED DNA*
Susanne
Vikström
,
Lu
Li, and
Åke
Wieslander
From the Department of Biochemistry, Umeå University,
901 87 Umeå, Sweden
 |
ABSTRACT |
In membranes of Acholeplasma
laidlawii a single glucosyltransferase step between the major,
nonbilayer-prone monoglucosyl-diacylglycerol (MGlcDAG) and the
bilayer-forming diglucosyl-diacylglycerol (DGlcDAG) is important for
maintenance of lipid phase equilibria and curvature packing stress.
This DGlcDAG synthase is activated in a cooperative fashion by
phosphatidylglycerol (PG), but in vivo PG amounts are not
enough for efficient DGlcDAG synthesis. In vitro,
phospholipids with an sn-glycero-3-phosphate backbone, and
no positive head group charge, functioned as activators. Different
metabolic, soluble phosphates could supplement PG for activation,
depending on type, amount, and valency. Especially efficient were the
glycolytic intermediates fructose 1,6-bisphosphate and ATP, active at
cellular concentrations on the DGlcDAG but not on the preceding MGlcDAG synthase. Potencies of different phosphatidylinositol (foreign lipid)
derivatives differed with numbers and positions of their phosphate
moieties. A selective stimulation of the DGlcDAG, but not the MGlcDAG
synthase, by minor amounts of double-stranded DNA was additive to the
best phospholipid activators. These results support two types of
activator sites on the enzyme: (i) lipid-phosphate ones close to the
membrane interphase, and (ii) soluble (or particulate)-phosphate ones
further out from the surface. Thereby, the nonbilayer (MGlcDAG) to
bilayer (DGlcDAG) lipid balance may be integrated with the metabolic
status of the cell and potentially also to membrane and cell division.
 |
INTRODUCTION |
The "melted," i.e. liquid-crystalline
(L
), state of the lipids in biological
membranes is essential for many membrane-associated processes. The
types of polar lipid species are also important. In the small cell
wall-less prokaryote Acholeplasma laidlawii an extensive
metabolic regulation in the amounts of the major phospholipids and
glucolipids occurs under a variety of conditions (e.g. see
Refs. 1 and 2). This serves to maintain (i) a certain surface charge
density, (ii) phase equilibria close to a potential bilayer to
nonbilayer transition, and (iii) a nearly constant spontaneous
curvature for the lipid bilayer. However, A. laidlawii
cannot efficiently regulate the melting temperature of the lipids (3).
The properties (i-iii) are believed to be important for the functional
characteristics of many membrane proteins and a readiness for local
structural transformations in/of the membrane (4-7). Similar
principles also apply to membrane lipid composition in
Escherichia coli (8, 9) and probably many bacteria. Starting
from the common precursor phosphatidic acid
(PA),1 the pathways of the
syntheses in vivo of the major A. laidlawii lipids (in bold) are tentatively as shown in Scheme 1.
|
|
|
|
The two major glucolipids, the nonbilayer-prone
monoglucosyldiacylglycerol (MGlcDAG) and the bilayer-forming
diglucosyldiacylglycerol (DGlcDAG), are key lipids for regulation of
the packing properties (ii and iii above) under many conditions. This
is mainly accomplished by a metabolic altering in the relative amounts
of the two lipids. The two membrane-bound glucolipid-synthesizing
enzymes (glucosyltransferases) must sense bilayer packing properties
directly or get specific communicating signals, which activate the
genes encoding these enzyme, or modify activities of the enzymes. The
MGlcDAG synthase is dependent upon a lipid environment where a critical
fraction of anionic amphiphiles must be present in substantial amounts (10, 11). A conformational change and activation of the enzyme is
mediated by these anionic lipids (12), and it seems to be the main site
for the lipid surface charge regulation, balancing the phospholipid and
glucolipid pathways. PG is particularly important because the
consecutively acting DGlcDAG synthase is only active, in a cooperative
fashion, in the presence of substantial amounts of an activator lipid,
especially PG. The nonbilayer/bilayer lipid balance and curvature are
more likely regulated by the synthesis of DGlcDAG because this step is
strongly stimulated by certain nonbilayer-prone additives in
vitro (13, 14) but also by "patching" of the activator PG
(15).
A potential coupling between the bilayer packing properties brought by
the MGlcDAG/DGlcDAG balance, and cell metabolism, is anticipated from a
correlation between the glucolipid ratio and cellular energetics,
i.e. the transmembrane electrical potential, the cellular
K+ and ATP content, and glucose consumption, respectively
(16, 17). Nucleotide phosphates also affect the two
glucosyltransferases differently in vitro (18), and certain
soluble phosphates stimulated the purified DGlcDAG synthase (14).
Important phosphate molecules in Mycoplasmas are, in addition to RNA,
DNA, polyphosphates, and phospholipids (19), also fructose
1,6-bisphosphate (FBP) and ATP (20). Amounts of the latter two are also
strongly correlated to the extent of glucose consumption (glycolysis)
in related Gram-positive bacteria (21, 22). Furthermore, FBP is an
important gene regulator for metabolic responses in such bacteria (23)
and an activator for the lactate dehydrogenase in A. laidlawii (24).
We report here for the purified DGlcDAG synthase that there is strong
support for a coupling between bilayer packing properties and the
general metabolic status of the cell. Several important phosphate-containing metabolites stimulated the DGlcDAG synthase activity substantially and additive to PG. The preceding MGlcDAG synthase was indifferent to these phosphate compounds.
 |
MATERIALS AND METHODS |
Strain and Growth Conditions--
For enzyme purification
A. laidlawii strain A-EF22 was cultivated in an oleic acid
(18:1c)-supplemented medium (13). For variation in lipid acyl chain
length (Cn) and unsaturation (% UFA), A. laidlawii
was grown with one saturated (8, 12, 14, 16, 18, 20, or 22 carbons
chain length) plus one monounsaturated fatty acid (14, 16, 18, 20, or
22 carbons chain length), with five or six combinations within each
pair and a total concentration of 150 µM (25).
Incorporation into the membrane lipids was monitored by added
14C- and 3H-labeled fatty acids. Extraction,
separation by TLC, and quantitation of the lipids by liquid
scintillation counting and gas-liquid chromatography was performed as
described (25).
Lipids and Other Material--
MGlcDAG was prepared from
A. laidlawii grown in the presence of oleic acid, which
gives polar lipids with more than 90% (mol/mol) 18:1c acyl chains
(13). Synthetic rac-1,2-dioleoylglycerol (1,2-DOG) and
1,3-dioleoylglycerol (1,3-DOG) were purchased from Larodan (Sweden).
1,2-Dioleoylphosphatidic acid (DOPA), 1,2-dioleoylphosphatidylglycerol (DOPG), 1,2-dioleoylphosphatidylserine (DOPS),
1,2-dioleoyl-phosphatidylcholine (DOPC),
1,2-dioleoyl-phosphatidylinositol (DOPI), and bovine heart diphosphatidylglycerol (DPG) were purchased from Avanti Polar Lipids.
Immobilized proteinase K was purchased from Merck. Fructose 1,6-bisphosphate, phosphoenolpyruvate, ADP, ATP, GTP, CTP, UDP, UTP,
and tetrasodium pyrophosphate were from Roche Molecular Biochemicals. RNA, phosphatidylinositol 4-monophosphate (PIP), phosphatidylinositol 4,5-bisphosphate (PIP2), sn-glycero-3-phosphate
(G-3-P), and sn-glycero-1-phosphate (G-1-P; racemic, also
containing some G-3-P) were purchased from Sigma.
Sodium-meta-vanadate was purchased from Riedel-de Haën (Germany). Sodium molybdate was purchased from KEBO (Sweden). DNA was
prepared from A. laidlawii using the Rapid
PrepTM Kit (Amersham Pharmacia Biotech). Control template
DNA was purchased from Perkin-Elmer (PCR Reagent Kit).
Purification of Glucosyltransferases--
DGlcDAG synthase was
purified from detergent-solubilized A. laidlawii cells by
ion exchange, hydroxyapatite, and dye ligand affinity chromatography
according to Ref. 14. Homogenous and detergent-free MGlcDAG synthase
was purified according to (12).
Assay for Glucosyltransferase Activity--
Assays in mixed
micelles were technically performed as described before (11, 14). The
CHAPS assay buffer contained 18.8 mM CHAPS, 100 mM Tris maleate, pH 8, and 5-20 mM
MgCl2. Standard lipid concentration used was 11.2 mM (0.3 mM substrate, 7.5 mM (25 mol %) lipid activator, and 3.4 mM matrix lipids (DOPC, if not otherwise stated)). The procedure was modified, however; the assay
time used was 30 min, and 4 µl of enzyme solution (
0.08 µg of
protein) was added to 86 µl of micellar solution. Reactions were
started by addition of 10 µl of UDP-[14C]glucose to
give a concentration of 1 mM in a final volume of 100 µl
of assay buffer. For assays with PI, PIP, and PIP2 the assay volume was reduced to 50 µl, and the lipid composition was 6 mM DOPG (20 mol %) and 4.9 mM matrix lipids.
After 30 min at 28 °C, reactions were stopped with 375 µl of
methanol/chloroform, 2:1 (v/v), and the lipids, including newly
synthesized MGlcDAG or DGlcDAG, were extracted and separated by TLC as
described (10) and then quantified using electronic autoradiography
(Packard Instant Imager).
Limited Proteolytic Digestion of DGlcDAG Synthase--
DGlcDAG
synthase (2.3 µg, 15 µl) was incubated with lipid mixed micelles at
a final concentration of 10 mM lipids, 110 mM Tris maleate, 20 mM MgCl2, 20 mM
CHAPS, pH 8, for 30 min on ice. In the samples with 100 or 800 mM phosphate, no magnesium was present. Immobilized
proteinase K (0.01 unit) was then added to the mixed micelles and
gently shaken at 28 °C for 20 min. Proteolysis was terminated by
removing the immobilized proteinase using centrifugation at 2,000 × g. Supernatants were analyzed by SDS-polyacrylamide gel
electrophoresis, using 15% acrylamide in the resolving gel (26), and
proteins were visualized by silver staining.
 |
RESULTS |
DGlcDAG and PG Amounts in Vivo and in Vitro--
The presence of
substantial amounts of activator PG for DGlcDAG synthesis is crucial
in vitro, both with crude cellular proteins and the purified
enzyme (13, 14). In vivo there is a correlation between
these two lipids; Fig. 1A
shows the PG and DGlcDAG amounts in many different A. laidlawii cultures, and Fig. 1B shows the DGlcDAG
synthesis in vitro. The lower PG amounts in vivo
(Fig. 1A) should not be sufficient for achieving a strong
DGlcDAG synthesis in vitro, according to Fig. 1B.
Furthermore, the substantial stimulation at high PG concentration
caused by nonbilayer-prone molecules, like 1,3-DOG (Fig.
1B), is much less pronounced at lower PG amounts (i.e. 10-15 mol %) (13).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
DGlcDAG and activator PG in vivo
and in vitro. A, correlation
between PG and DGlcDAG amounts in A. laidlawii membranes.
Cells were grown with a variety of fatty acids (see "Experimental
Procedures"), yielding large differences in lipid chain length
(Cn) and monounsaturation (% UFA). Open circles,
average lipid amounts of PG and DGlcDAG with Cn (1)
<15, (2) 15-16, (3) 16-17, (4)
17-18, (5) 18-19, and (6) >19. Filled circles, average
amounts for the two lipids with % UFA (A) <20,
(B) 20-40, (C) 40-60, (D) 60-80,
and (E) >80 mol %. Regression lines are shown, and
correlation coefficients were 0.95 and 0.97, respectively. Lipids
decreasing concomitantly are MGlcDAG and the phosphoglucolipids. Part
of the data (PG) is from Ref. 25. B, DGlcDAG enzymatic
synthesis in vitro with DOPG as activator in (open
circles) mixed micelles (14), and (filled circles)
liposome models (13). Dashed arrows, stimulation by addition
of nonbilayer-prone 1,3-DOG (11.5 and 15 mol %, open and
filled squares). Values are normalized relative to the
activity rate (V, nmol/h) with 25 mol % PG present.
|
|
These data indicate that the amounts of the "essential" activator
PG may not be sufficient to achieve enough DGlcDAG synthesis at
in vivo conditions. Therefore, several cellular
phosphate-containing molecules, where the phosphate moieties are
located in similar carbon molecular environments (see Fig.
2), were analyzed for their ability to
support activation of the DGlcDAG synthase by PG.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Schematic structures of phosphate-containing
metabolites used. A, PA is the structural base for the
phospholipids. The backbone of PA (and the other phospholipids) is
sn-glycero-3-phosphate (G-3-P), whereas G-1-P is the polar
head group of PG. B, Pi; C, PEP;
D, FBP; E, ATP; F, DNA (RNA). A
circled P corresponds to a phosphate moiety.
|
|
Activation of DGlcDAG Synthase by Phosphate and Mg2+
Ions--
The DGlcDAG synthase can bind to a calcium phosphate matrix
and subsequently be released by 300-400 mM phosphate (14).
Many glucosyltransferases have a requirement for Mg2+ as a
cofactor (27). The influence of phosphates and magnesium ions on the
DGlcDAG synthase was analyzed at an activator PG concentration yielding
a fairly low enzyme activity (25 mol %, cf. Fig.
1B). For the DGlcDAG synthase the dependence of
Mg2+ peaked at ~10 mM Mg2+ (Fig.
3A); some Mg2+ may
still be bound to the enzyme after the purification procedure. The
inhibition by Mg2+ at higher concentrations might be due to
interaction with the soluble substrate UDP-Glc (1 mM).
Inorganic phosphate stimulated the enzyme activity 5-fold at 20 mM with only 5 mM Mg2+ present
(Fig. 3A). sn-Glycero-1-phosphate (G-1-P; also
containing some G-3-P) had a stimulating effect on the DGlcDAG
synthesis activity above 15 mM but lower than for the free
phosphate (Fig. 3A). The activity maximum appeared at 40 mM; far above a physiological concentration. On the other
hand, G-3-P strongly inhibited the enzyme (Fig. 3A). G-3-P
is the backbone of PG (and the other phospholipids used, Fig. 2), and
G-1-P is identical to the PG head group. With no Mg2+
added, inorganic phosphate increased the enzyme activity about 16 times
at 20 mM phosphate (Fig. 3B); with
Mg2+ present the DGlcDAG maximum activity decreased with
increasing concentrations of Mg2+ (Fig. 3B).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of phosphate and Mg2+
ions on the DGlcDAG synthase activity. The DGlcDAG activity
(V, nmol/h) was measured in CHAPS mixed micelles (25 mol % DOPG activator) as a function of potassium phosphate, Mg2+,
sn-glycero-1- or -3-phosphate (A); phosphate plus
Mg2+ (B). Curves are normalized
relative to their common point where no ions were added.
|
|
Hence, these experiments show that, at corresponding concentrations and
low PG activator, certain soluble phosphates stimulated DGlcDAG
synthase activity substantially and more than Mg2+. Most
important, the soluble G-3-P analog of the PG backbone inhibited the
enzyme strongly.
Important Cell Metabolites Influence the Nonbilayer/Bilayer Lipid
Balance--
The substantial stimulation of DGlcDAG synthesis with
small soluble phosphates (above) prompted a screening of other
important phosphorylated cell metabolites. For this, the
Mg2+ and DOPG concentrations were maintained at a low but
physiological and responsive levels. Of ADP, ATP, CTP, GTP, UDP, and
UTP at physiological concentrations (0.5 mM), especially
ATP stimulated the DGlcDAG synthase, whereas the MGlcDAG synthase was
more indifferent (data not shown). Several key phosphorylated
intermediates in the glycolysis were also tested. Fructose
1,6-bisphosphate (FBP) increased the DGlcDAG synthase activity, with a
sharp rise up to 1 mM FBP. The activity maximum
corresponded to an 18-fold stimulation (Fig.
4); concentrations of FBP higher than
~1 mM yielded lower activity but a stimulation still
persisted at 2 mM FBP (Fig. 4). In contrast, activity of
the preceding MGlcDAG synthase remained the same in the presence of
increasing FBP (Fig. 4). Several enzymatic reactions in A. laidlawii, including the synthesis of FBP from fructose
6-phosphate is dependent on pyrophosphate (PPi) (28). The
DGlcDAG synthesis increased ~5-fold when 0.5 mM
PPi was present; for the preceding MGlcDAG synthesis no
effect (or a slight decrease) was observed (data not shown). The
glycolytic intermediate phosphoenolpyruvate (PEP), which often has a
regulatory role in cell metabolism, was also analyzed at physiological
concentrations. The DGlcDAG activity increased up to 0.5 mM
PEP and an enhancement of the enzyme activity
4× was observed (Fig.
4). However, for the MGlcDAG synthase PEP had essentially no influence
on the activity (Fig. 4).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
The influence of important cellular
metabolites on the DGlcDAG and MGlcDAG syntheses. The MGlcDAG
(open symbols) and DGlcDAG synthases activity (filled
symbols) were measured in CHAPS mixed micelles (25 mol DOPG % activator, 5 mM Mg2+). FBP, PEP, and ATP
concentrations were increased stepwise. Curves are normalized relative
to the common point where no metabolites were added. The single curve
shown for MGlcDAG synthesis is valid for the three different
additives.
|
|
A. laidlawii obtains its ATP demand from substrate level
phosphorylation only (28). For the DGlcDAG synthase, enzyme activity increased up to an ATP concentration of 0.75 mM, yielding a
12-fold stimulation (Fig. 4). Concentrations higher than 1.5 mM inhibited the enzyme. The MGlcDAG synthase activity was
not altered by the ATP concentration range examined. The latter
coincides with the range of ATP concentration recorded in A. laidlawii cells (17, 29), related bacteria (21, 30), and slow
growing E. coli (31). The MGlcDAG synthase is strongly
dependent on Mg2+ ions, but no inhibition was observed at
raised ATP concentrations. Hence, the inhibition of the DGlcDAG
synthase at the higher ATP concentrations is probably not a chelating
effect of ATP on the Mg2+ ions. At 10 mM ATP
with 20 mM Mg2+ present, both enzymes were
totally inhibited. However, two established competitive molecules of
phosphate in protein-binding sites, vanadate and molybdate (see
"Experimental Procedures"), both stimulated the DGlcDAG synthase at
low concentrations. This was especially the case for vanadate (more
than 2× stimulation at 0.5 mM; data not shown), supporting
the role of phosphate-binding sites on the DGlcDAG synthase (above).
The cellular phosphorylated compounds analyzed contain different
numbers of phosphate moieties (Fig. 2) and stimulated the activity of
the DGlcDAG but not the MGlcDAG synthase. Comparing ATP (3 phosphates)
with FBP and PPi (2 phosphates), it seems that three or two
phosphates in a row was not as effective as the two at the opposite
ends in FBP (cf. Fig. 2). This implies that a simultaneous
interaction with several phosphate-binding sites is more effective.
Numbers and Positions of Lipid Head Group Phosphates Are
Crucial--
The potential importance of activator phosphate numbers
and localization was monitored using different phosphate-substituted phosphatidylinositol (PI) lipids (Fig. 2). Inositol phosphates are
important intracellular second messengers in eukaryotic cells; however,
they don't exist in A. laidlawii. The endogenous DOPG was
used as the activator, at a deliberately low (20 mol %) activating level (cf. Fig. 1B).
The DGlcDAG synthase activity increased with the concentration of PI
derivatives, i.e. PI efficiently supplemented PG for an
enhanced activation (Fig. 5). The numbers
and positions of the phosphate moieties on the inositol ring were also
important (Fig. 5). A stronger increase in DGlcDAG synthesis was
obtained with very low amounts of PIP2; much higher amounts
of PI were required to achieve a similar activity (Fig. 5). PIP showed
no evident stimulation of the enzyme activity at similarly low
fractions, indicating that the phosphate on carbon 4 in the inositol
ring of PIP (cf. Fig. 2) may not be able to reach the
presumed phosphate-binding pocket on the DGlcDAG synthase.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
Activator lipid phosphate positions are
important for the DGlcDAG synthase. Enzyme activities were
monitored in CHAPS mixed-micelles containing low amounts (20 mol %) of
activator DOPG and different phosphatidylinositol derivatives,
i.e. PI, PIP, and PIP2 (balance DOPC).
Curves are normalized relative to the common point where no
PI derivatives were added. The single curve for MGlcDAG synthesis is
valid for the three different additives. PIP and PIP2 could
only be assayed up to 2 mol % due to precipitation by Mg2+
at higher concentrations.
|
|
These findings strongly support a cooperative mechanism for activation
of the DGlcDAG synthase by lipid phosphates, where accessibility is
important. The MGlcDAG synthase activity was not influenced by the
small concentrations of the potent PI derivatives.
Activator Phosphates Induce a Conformational Change of the DGlcDAG
Synthase--
Activator phosphates may induce a close approach of the
membrane-bound enzyme (or the active site) to the bilayer surface and/or a conformational change. This was assessed by sensitivity to
proteolytic degradation. The resistance of the enzyme against proteinase K digestion in the different mixed micelles was visualized by SDS-polyacrylamide gel electrophoresis (Fig.
6). With CHAPS detergent only, and no
lipids present, the DGlcDAG synthase could be totally digested.
However, the enzyme revealed a high protease resistance in DOPG- or
phosphate-containing micelles. Some enzyme activity could be obtained
in micelles containing DOPS (14), but still the enzyme was not
protected against proteolytic cleavage in DOPS (Fig. 6). Denaturated
DGlcDAG synthase could not be protected from proteolytic digestion even
when the most protective lipid conditions were used (data not shown).
The presence of Mg2+ had no influence; the enzyme was
protected in PG micelles with or without Mg2+ ions.
However, it was found that by extended incubation times the enzyme
could be digested also at the most protective conditions. Hence, the
enzyme is not totally protected from digestion by being active.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
The proteolytic resistance of DGlcDAG
synthase in different lipid mixed micelles. Silver-stained SDS gel
with the DGlcDAG synthase after digestion by proteinase K in different
lipid/CHAPS mixed micelles for 20 min at 28 °C. Small digested
fragments were rarely seen. Sample composition is as follows: enzyme
(2.3 µg), 10 mM (33 mol %) lipid, 20 mM
CHAPS, and 20 mM MgCl2 (no MgCl2
was added with abundant phosphate). Lanes 1 and
2, enzyme in CHAPS only; lane 3, in DOPG/CHAPS;
lane 4, in DOPS/CHAPS; lane 5, in DOPG/CHAPS
without Mg2+; lane 6, in 100 mM
phosphate/CHAPS; and lane 7, in 800 mM
phosphate/CHAPS. Lane 1 without and lanes 2-7
with proteinase K. A copurified 30-kDa protein also present (14) was
degraded at all conditions (data not shown).
|
|
Soluble phosphate stimulated the activity 16-fold (Fig. 3). Could
phosphate protect the enzyme by itself, without PG? Since the surface
concentration of the PG activator is very high, it was necessary to
raise the soluble phosphate concentration substantially. The DGlcDAG
synthase was indeed protected from digestion at 800 mM (but
not by 100 mM) phosphate and no PG present (Fig. 6); hence, the phosphate need not be attached to a lipid.
These results show that there is a correspondence between high
activity, induced by phosphates, and proteolytic resistance for the
DGlcDAG synthase. Furthermore, both lipid-associated and free (soluble)
phosphate could induce this conformational change.
dsDNA Stimulates the DGlcDAG Synthase Activity--
Another major
source of phosphates in a cell is the nucleic acids. The structure of
nucleic acids influences how their phosphate moieties are exposed.
Double-stranded (ds) DNA from A. laidlawii and phage lambda,
a single-stranded (ss) DNA (oligo primer), and ssRNA were analyzed. The
two dsDNAs increased the activity of DGlcDAG synthase 7-fold when 0.7 µg of DNA/ml was added (20 µg enzyme/ml), corresponding to 2 µM DNA phosphates (Fig. 7).
This amount of DNA phosphate is very low compared with the amount of soluble phosphate needed for a similar stimulation (Fig. 3A)
or the concentration of nucleic acids in E. coli, for
example, at least 0.35 M expressed as DNA phosphates
(75-120 mg of DNA/ml) (32). It is also much less than the amount of
DOPG activator in the samples, i.e. 7.5 mM, or
the potent PI derivatives used (up to 0.6 mM; Fig. 5).
Neither the ssDNA nor RNA yielded any significant influence on DGlcDAG
synthase activity, and neither of the nucleic acids affected the
MGlcDAG synthase (Fig. 7).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 7.
DNA stimulates glucosyltransferase
activity. The MGlcDAG synthase activity (open bars) and
DGlcDAG synthase activity (filled bars) were measured in
mixed micelles (25 mol % DOPG). Different concentrations dsDNA were
added; µM DNA phosphates was obtained from the average
base composition of A. laidlawii DNA (32 mol % G + C).
Bars are normalized relative to their common point where no
DNA was added. Stimulation of the DGlcDAG synthase persisted up to at
least 20 µM DNA phosphate.
|
|
Stimulation by dsDNA Is Additive to Phospholipid
Activation--
The phospholipids PA, PG, and diphosphatidylglycerol
(DPG) have different glycerophosphate constituents (Fig. 2), analogous to the soluble phosphates analyzed in Fig. 3. Both DOPA and DPG were
substantially better activators for the purified DGlcDAG synthase than
DOPG, see Fig. 8. However, their
potencies declined at higher concentrations, perhaps due to their
stronger interaction with Mg2+ ions compared with PG.
Addition of small amounts of dsDNA to DPG (and PG) substantially
increased the extent of activation for the DGlcDAG synthase, also
shifting the activation curve toward higher efficiency at lower
activator amounts.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 8.
DNA potentiates activator phospholipid.
The influence of dsDNA on the DGlcDAG activity was analyzed as in Fig.
7, with different amounts of DOPA, DPG, and DOPG as activator
phospholipids (balance DOPC). Filled boxes and
circle, 2 µM DNA phosphates added to the DPG
and PG samples, respectively.
|
|
Hence, the double-stranded DNA probably interacts with the DGlcDAG
enzyme, presumably by its structurally organized phosphates, and
consequently strongly increases the activity. The potentiation of
activation, even with the best phospholipid activators, supports the
presence of several phosphate-binding sites on the enzyme. The small
amounts of DNA involved rule out a general change of the micellar properties.
 |
DISCUSSION |
Recent data indicated that it is not the actual "curvature
stress" (spontaneous curvature) that sets the DGlcDAG synthase activity but instead access of activators (like PG) or exposure of
phosphate-binding sites by the curvature that are important (14). The
amounts of activator PG maintained in A. laidlawii in vivo
are substantially less than amounts needed to yield average or high
synthesis rates of DGlcDAG in vitro (Fig. 1, A
and B), and other factors must therefore also be involved.
Activator Phospholipids--
From the data reported here it is
evident that PA, DPG, and PG can all work as efficient activator
lipids, where the two former were more potent (Fig. 8). PA is a
precursor present at minor and not sufficient amounts in
vivo, and DPG is not normally present in the A-EF22 strain used
but occurs in several other strains. Indeed, more DPG
(versus PG) correlates with more DGlcDAG (versus MGlcDAG) in the latter strains (33). The efficiencies of PA and DPG
(but not PG) are probably enhanced by the Mg2+ present
(Fig. 8). DOPA and E. coli DPG both become more
nonbilayer-prone upon interaction with divalent cations like
Mg2+, decreasing head group repulsion (34-36); an enhanced
curvature stress in the mixed micelles (Fig. 8) is thus likely.
The G-3-P backbone of phospholipids have a perpendicular orientation at
the bilayer interface, followed by a tilted head group further out (37,
38). Potent activator lipids of the DGlcDAG synthase all have this
part; positively charged moieties covalently linked outside the
phosphate (like in PC) prevent activation, whereas a zwitterion (like
in PS) works, and no or negative charges (like in PG, DPG, and PI
derivatives) (cf. Fig. 2) are very efficient (above and see
Refs. 10, 11, 13, and 14). The strong inhibition of the DGlcDAG
synthase by soluble G-3-P (Fig. 3) is most likely due to a competition
with the lipid activator phosphate in sites close to the interphase.
A heterogeneous distribution of lipid activator may yield higher local
activator concentrations and consequently higher enzyme activities.
Domain formation by PG with a concomitant stimulation of the DGlcDAG
synthase can be induced by a chain length mismatch in vitro
(15) and may occur in vivo (39, 40). Involvement of several
PG molecules for the activation event is supported by a close fit to
(cooperative) Hill kinetics, where Hill coefficients ranged between 3 and 7, and PG amounts needed were dependent on the bilayer environment
(10). The bilayer surface association of protein kinase C is similarly
dependent upon PS, with slightly larger Hill coefficients for binding
of 8 PS molecules (41).
Activation by Phosphorylated Metabolites and DNA--
Small single
phosphate-containing molecules like (soluble) inorganic or G-1-P
enhanced the activation potency of PG (Fig. 3A). An
interference by Mg2+ ions was also obvious (Fig.
3B). Note that the enzyme is associated with the micelles by
hydrophobic interactions (14). A very large, soluble phosphate
concentration (800 mM) could replace the demand for PG (7.5 mM/25 mol %) in inducing a conformational change (Fig. 6).
Mycoplasmas may contain 40 mM orthophosphate, which
decrease upon glycolysis (19, 20). Mg2+ binds strongly to
oligo- and polyphosphates (42) and adsorbs to and lowers the bilayer
surface potential of phospholipids like PG (6, 43). The intracellular
concentration of Mg2+ is
100 mM in E. coli (44), and A. laidlawii membranes (lipids) bind
25% that in the E. coli cell envelope (114 µmol/g)
(44, 45). Hence, Mg2+ is present and important for the
DGlcDAG synthase (Fig. 3).
The di- or triphosphate-containing metabolites FBP, PPi,
and ATP were strong potentiators of PG activation in the low
mM (physiological) range (Fig. 4). The lower amounts needed
strongly indicates an enhanced binding to the DGlcDAG synthase. Both
ATP and FBP are important energy and signaling molecules in the
Gram-positive bacteria including Mycoplasmas and are correlated to the
cellular growth state. The very strong effects especially by FBP (Fig. 4), similar to that of PIP2 (Fig. 5), indicate that a
certain spacing between the phosphate moieties, like in FBP but not in ATP (Fig. 2), is more optimal for binding or reach more sites on the
enzyme. Since these metabolites could achieve higher activities of the
DGlcDAG synthase than for PG alone, the enzyme most likely contain
activator sites not reachable by PG (but probably by PIP2). The latter sites are obviously also not as specific as the G-3-P-lipid sites at the interphase (proposed above).
The multiphosphate dsDNA had an activating potency on the DGlcDAG
synthase at very low (µM) concentrations, which was
additive to the best phospholipid activators (Fig. 8). The distances
between phosphates in dsDNA backbone (Fig. 2) and across the minor
groove, but not across the substantially larger major groove, are
fairly similar to the phosphate distances in PIP2, for
example. Hence, with the dsDNA (but not ssDNA or RNA) an ordered
oligophosphate template is probably exposed toward the enzyme. An
average aggregate size of 100 molecules, for example, in the
lipid-CHAPS micelles (14) gives a micelle concentration of 0.3 mM (enzyme 15 nM). 2 µM DNA
phosphate A. laidlawii dsDNA corresponds to a few
pM DNA; broken into many fragments upon purification a few
nM DNA is reached, not enough for one piece of DNA per
enzyme. However, one DNA fragment may engage several enzymes. The
diameter of a dsDNA helix (
2 nm) may be too large to be accommodated
between the membrane-associated DGlcDAG synthase (40 kDa) and the
bilayer surface.
Hence, the stimulation brought by the DNA supports two types of binding
sites on the enzyme as follows: (i) lipid-phosphate ones close to the
membrane surface, and (ii) soluble or particulate phosphate sites
further out on the side of the enzyme, where the latter are accessible
by metabolites and DNA. Various phosphate-containing molecules
obviously can act in a synergistic manner. The lack of response by the
preceding MGlcDAG synthase toward the metabolites and DNA opens up for
a multifaced control of the nonbilayer (MGlcDAG)/bilayer (DGlcDAG)
lipid balance.
Functional Consequences for the Cell--
The phosphorylated
molecules investigated are all connected with the extent of cell
growth, except the phospholipids. Hence, metabolic concentrations of
these may act as signals upon the DGlcDAG synthase, causing the enzyme
to make more DGlcDAG (bilayer-forming) and consequently depleting the
MGlcDAG pool (nonbilayer-prone), cf. Fig.
9. It was recently found in E. coli that the major membrane nonbilayer phospholipid,
phosphatidylethanolamine (PE), plays an essential role at some stage in
the cell division process (46), and PE-deficient mutants failed to
divide properly. Mycoplasmas seem to lack the later components of this
Fts cell division assembly (47). Accumulation of nonbilayer lipids in
the membrane of A. laidlawii may trigger, or be beneficial
to, membrane and cell division. Expansion of the membrane, needed for
cell growth, would consequently be stimulated by the phosphorylated
metabolites, PG, and the (DNA) chromosome, acting in a cooperative
fashion.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 9.
Regulatory mechanisms for the DGlcDAG
synthase. Speculative sketch indicating the activating and
stimulatory molecules, which act in a cooperative fashion. Molecular
sizes are presented roughly in scale. The balance between MGlcDAG and
DGlcDAG may be coupled to membrane (cell) division and growth.
|
|
 |
ACKNOWLEDGEMENTS |
We thank Drs. Dennis Pollack, University of
Ohio, Columbus, and Kevin Dybvig, University of Alabama at Birmingham,
for valuable comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported by the Swedish Natural Science
Research Council and the K. and A. Wallenberg Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry,
Umeå University, 901 87 Umeå, Sweden. Fax: +46-90-786-7661; E-mail:
ake@biokemi.su.se or susanne.vikstrom@chem.umu.se.
 |
ABBREVIATIONS |
The abbreviations used are:
PA, phosphatidic acid;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate;
1, 2-DAG,
1,2-diacylglycerol;
DGlcDAG, 1,2-diacyl-3-O-[
-D-glucopyranosyl-(1
2)-O-
-D-glucopyranosyl]-sn-glycerol;
DO, dioleoyl;
1, 3-DOG, 1,3-dioleoylglycerol;
DPG, diphosphatidylglycerol;
FBP, fructose 1,6-bisphosphate;
Glc, glucose;
G-1-P, sn-glycero-1-phosphate;
G-3-P, sn-glycero-3-phosphate;
MGlcDAG, 1,2-diacyl-3-O-(
-D-glucopyranosyl)-sn-glycerol;
Pi, inorganic phosphate;
PPi, pyrophosphate;
PC, phosphatidylcholine;
PE, phosphatidylethanolamine;
PEP, phosphoenolpyruvate;
PG, phosphatidylglycerol;
PS, phosphatidylserine;
PI, phosphatidylinositol;
PIP, phosphatidylinositol-4-phosphate;
PIP2, phosphatidylinositol-4,5-bisphosphate;
dsDNA, double-stranded DNA;
UFA, unsaturated fatty acid;
DOPA, 1,2-dioleoylphosphatidic acid;
DOPG, 1,2-dioleoylphosphatidylglycerol;
DOPS, 1,2-dioleoylphosphatidylserine;
DOPC, 1,2-dioleoyl-phosphatidylcholine;
DOPI, 1,2-dioleoyl-phosphatidylinositol;
ss, single-stranded.
 |
REFERENCES |
| 1.
|
Rilfors, L.,
Wieslander, Å.,
and Lindblom, G.
(1993)
in
Subcellular Biochemistry: Mycoplasma Cell Membranes
(Rottem, S.
, and Kahane, I., eds), Vol. 20
, pp. 109-166, Plenum Publishing Corp., New York
|
| 2.
|
Österberg, F.,
Rilfors, L.,
Wieslander, Å.,
Lindblom, G.,
and Gruner, S. M.
(1995)
Biochim. Biophys. Acta
1257,
18-24[Medline]
[Order article via Infotrieve]
|
| 3.
|
McElhaney, R. N.
(1992)
in
Mycoplasmas: Molecular Biology and Pathogenesis
(Maniloff, J.
, McElhaney, R. N.
, Finch, L. R.
, and Baseman, J. B., eds)
, pp. 113-155, American Society for Microbiology, Washington, D. C.
|
| 4.
|
Epand, R. M.
(1998)
Biochim. Biophys. Acta
1376,
353-368[Medline]
[Order article via Infotrieve]
|
| 5.
|
Epand, R. M.
(ed)
(1997)
Lipid Polymorphism and Membrane Properties
, Academic Press, San Diego
|
| 6.
|
McLaughlin, S.
(1989)
Annu. Rev. Biophys. Biophys. Chem.
18,
113-136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Gruner, S. M.
(1992)
in
The Structure of Biological Membranes
(Yeagle, P., ed)
, pp. 211-250, CRC Press, Inc., Boca Raton, FL
|
| 8.
|
Rietveld, A. G.,
Killian, J. A.,
Dowhan, W.,
and de Kruijff, B.
(1993)
J. Biol. Chem.
268,
12427-12433[Abstract/Free Full Text]
|
| 9.
|
Morein, S.,
Andersson, A. S.,
Rilfors, L.,
and Lindblom, G.
(1996)
J. Biol. Chem.
271,
6801-6809[Abstract/Free Full Text]
|
| 10.
|
Karlsson, O. P.,
Dahlqvist, A.,
and Wieslander, Å.
(1994)
J. Biol. Chem.
269,
23484-23490[Abstract/Free Full Text]
|
| 11.
|
Karlsson, O. P.,
Dahlqvist, A.,
Vikström, S.,
and Wieslander, Å.
(1997)
J. Biol. Chem.
272,
929-936[Abstract/Free Full Text]
|
| 12.
|
Li, L.,
Karlsson, O. P.,
and Wieslander, Å.
(1997)
J. Biol. Chem.
272,
29602-29606[Abstract/Free Full Text]
|
| 13.
|
Dahlqvist, A.,
Nordström, S.,
Karlsson, O. P.,
Mannock, D. A.,
McElhaney, R. N.,
and Wieslander, Å.
(1995)
Biochemistry
34,
13381-13389[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Vikström, S.,
Lu, L.,
Karlsson, O. P.,
and Wieslander, Å.
(1999)
Biochemistry
38,
5511-5520[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Karlsson, O. P.,
Rytömaa, M.,
Dahlqvist, A.,
Kinnunen, P. K. J.,
and Wieslander, Å.
(1996)
Biochemistry
35,
10094-10102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Clementz, T.,
Christiansson, A.,
and Wieslander, Å.
(1986)
Biochemistry
25,
823-830[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Clementz, T.,
Christiansson, A.,
and Wieslander, Å.
(1987)
Biochim. Biophys. Acta
898,
299-307[Medline]
[Order article via Infotrieve]
|
| 18.
|
Dahlqvist, A.,
Andersson, S.,
and Wieslander, Å.
(1992)
Biochim. Biophys. Acta
1105,
131-140[Medline]
[Order article via Infotrieve]
|
| 19.
|
Lajeunesse, D.,
and Le Grimellec, C.
(1984)
Can. J. Biochem. Cell Biol.
62,
1041-1045[Medline]
[Order article via Infotrieve]
|
| 20.
|
Egan, W.,
Barile, M.,
and Rottem, S.
(1986)
FEBS Lett.
204,
373-376[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Mason, P. W.,
Carbone, D. P.,
Cushman, R. A.,
and Waggoner, A. S.
(1981)
J. Biol. Chem.
256,
1861-1866[Abstract/Free Full Text]
|
| 22.
|
Bond, D. R.,
and Russell, J. B.
(1998)
Appl. Environ. Microbiol.
64,
976-981[Abstract/Free Full Text]
|
| 23.
|
Hueck, C. J.,
and Hillen, W.
(1995)
Mol. Microbiol.
15,
395-401[Medline]
[Order article via Infotrieve]
|
| 24.
|
Neimark, H.,
and Tung, M. C.
(1973)
J. Bacteriol.
114,
1025-1033[Abstract/Free Full Text]
|
| 25.
|
Wieslander, Å.,
Nordström, S.,
Dahlqvist, A.,
Rilfors, L.,
and Lindblom, G.
(1995)
Eur. J. Biochem.
227,
734-744[Medline]
[Order article via Infotrieve]
|
| 26.
|
Nyström, S.,
Wallbrandt, P.,
and Wieslander, Å.
(1992)
Eur. J. Biochem.
204,
231-240[Medline]
[Order article via Infotrieve]
|
| 27.
|
Pieringer, R. A.
(1989)
in
Microbial Lipids
(Ratledge, D.
, and Wilkinson, S. G., eds)
, pp. 51-114, Academic Press
|
| 28.
|
Pollack, D. J.,
Williams, M. V.,
and McElhaney, R. N.
(1997)
Crit. Rev. Microbiol.
23,
269-354[Medline]
[Order article via Infotrieve]
|
| 29.
|
Beaman, K. D.,
and Pollack, J. D.
(1983)
J. Gen. Microbiol.
129,
3103-3110[Medline]
[Order article via Infotrieve]
|
| 30.
|
Otto, R.,
Klont, B.,
ten Brink, B.,
and Konings, W. N.
(1984)
Arch. Microbiol.
139,
338-343[CrossRef]
|
| 31.
|
Dahan-Grobgeld, E.,
Livneh, Z.,
Maretzek, A. F.,
Polak-Charcon, S.,
Eichenbaum, Z.,
and Degani, H.
(1998)
J. Biol. Chem.
273,
30232-30238[Abstract/Free Full Text]
|
| 32.
|
Record, M. T., Jr.,
Courtenay, E. S.,
Cayley, D. S.,
and Guttman, H. J.
(1998)
Trends Biochem. Sci.
23,
143-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Steinick, L. E.,
Wieslander, Å.,
Johansson, K.-E.,
and Liss, A.
(1980)
J. Bacteriol.
143,
1200-1207[Abstract/Free Full Text]
|
| 34.
|
Farren, S. B.,
Hope, M. J.,
and Cullis, P. R.
(1983)
Biochem. Biophys. Res. Commun.
111,
675-682[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Tilcock, C. P. S.,
Cullis, P. R.,
and Gruner, S. M.
(1988)
Biochemistry
27,
1415-1420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Killian, J. A.,
Kooregevel, M. C.,
Bouwstra, J. A.,
Gooris, G.,
Dowhan, W.,
and de Kruijff, B.
(1994)
Biochim. Biophys. Acta
1189,
225-232[Medline]
[Order article via Infotrieve]
|
| 37.
|
Pascher, I.,
Lundmark, M.,
Nyholm, P.-G.,
and Sundell, S.
(1992)
Biochim. Biophys. Acta
1113,
339-373[Medline]
[Order article via Infotrieve]
|
| 38.
|
Seelig, J.,
Macdonald, P. M.,
and Scherer, P. G.
(1987)
Biochemistry
26,
7535-7541[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Bevers, E. M.,
Singal, S. A.,
Op den Kamp, J. A. F.,
and van Deenen, L. L. M.
(1977)
Biochemistry
16,
1290-1295[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Bevers, E. M.,
Op den Kamp, J. A. F.,
and van Deenen, L. L. M.
(1978)
Biochim. Biophys. Acta
511,
509-512[Medline]
[Order article via Infotrieve]
|
| 41.
|
Mosior, M.,
and Newton, A. C.
(1998)
Biochemistry
37,
17271-17279[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Birch, N. J.
(ed)
(1993)
Magnesium and the Cell
, Academic Press, Cambridge
|
| 43.
|
Lau, A.,
McLaughlin, A.,
and McLaughlin, S.
(1981)
Biochim. Biophys. Acta
645,
279-292[Medline]
[Order article via Infotrieve]
|
| 44.
|
Chang, C.-F.,
Shuman, H.,
and Somlyo, A. P.
(1986)
J. Bacteriol.
167,
935-939[Abstract/Free Full Text]
|
| 45.
|
Kahane, I.,
Neíeman, Z.,
and Razin, S.
(1973)
J. Bacteriol.
113,
666-671[Abstract/Free Full Text]
|
| 46.
|
Mileykovskaya, E.,
Sun, Q.,
Margolin, W.,
and Dowhan, W.
(1998)
J. Bacteriol.
180,
4252-4257[Abstract/Free Full Text]
|
| 47.
|
Razin, S.,
Yogev, D.,
and Naot, Y.
(1998)
Microbiol. Mol. Biol. Rev.
62,
1094-1156[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. H. Alley, O. Ces, R. H. Templer, and M. Barahona
Biophysical Regulation of Lipid Biosynthesis in the Plasma Membrane
Biophys. J.,
April 15, 2008;
94(8):
2938 - 2954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lis and H. K. Kuramitsu
The Stress-Responsive dgk Gene from Streptococcus mutans Encodes a Putative Undecaprenol Kinase Activity
Infect. Immun.,
April 1, 2003;
71(4):
1938 - 1943.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Edman, S. Berg, P. Storm, M. Wikstrom, S. Vikstrom, A. Ohman, and A. Wieslander
Structural Features of Glycosyltransferases Synthesizing Major Bilayer and Nonbilayer-prone Membrane Lipids in Acholeplasma laidlawii and Streptococcus pneumoniae
J. Biol. Chem.,
February 28, 2003;
278(10):
8420 - 8428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Kiriukhin, D. V. Debabov, D. L. Shinabarger, and F. C. Neuhaus
Biosynthesis of the Glycolipid Anchor in Lipoteichoic Acid of Staphylococcus aureus RN4220: Role of YpfP, the Diglucosyldiacylglycerol Synthase
J. Bacteriol.,
June 1, 2001;
183(11):
3506 - 3514.
[Abstract]
[Full Text]
|
 |
|